在脊髓损伤的慢性阶段进行药理干预
1Section of Neuromedical Science, Institute of Natural Medicine, University of Toyama, Toyama, Japan.
Neural regeneration research
|June 27, 2024
概括
使用小化合物和蛋白质的药物治疗表明,在慢性脊髓损伤中,它有望促进轴突的再生. 尾酒疗法可能为这种难以治愈的疾病提供未来的治疗潜力.
科学领域:
- 神经科学是一个神经科学.
- 再生医学是一种再生医学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 脊髓损伤 (SCI) 是一种严重的创伤事件,导致永久失去运动和感官功能.
- 慢性SCI的特征是由于损伤部位的抑制因素和骨肌肉缩而导致的轴突再生抑制.
- 目前SCI的治疗策略在功能恢复方面取得了有限的成功.
研究的目的:
- 审查药物治疗方法,包括小化合物和蛋白质,以促进慢性脊髓损伤中的轴突生长.
- 根据临床前和临床研究确定有前途的候选药物用于SCI治疗.
主要方法:
- 对调查慢性脊髓损伤药物治疗的研究的文献综述.
- 针对轴突生长抑制和神经元存活的候选药物的分析.
- 评估体内动物研究和临床试验的结果.
主要成果:
- 一些药物治疗候选物,包括AA-NgR(310) ecto-Fc,fasudil,chondroitinase ABC和fampridine,在促进轴突生长方面表现出潜力.
- 这些药物针对慢性SCI环境中存在的各种抑制因素.
- 在基础研究和早期临床研究中观察到有希望的结果.
结论:
- 药理干预提供了治疗慢性脊髓损伤的潜在途径,通过促进轴突再生.
- 针对多种机制的组合疗法 (尾酒疗法) 可能对于克服慢性SCI的挑战至关重要.
- 需要进一步的临床研究来验证已识别的候选药物对SCI患者功能恢复的有效性.
相关概念视频
01:29Spasmolytic Agents: Chemical Classification
874
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
874
01:24Centrally Acting Muscle Relaxants: Therapeutic Uses
660
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
660
01:28Classification of Skeletal Muscle Relaxants
2.4K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.4K
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
658
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
658
01:09Peripherally and Centrally Acting Muscle Relaxants: A Comparison
3.2K
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
3.2K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
419
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
419